Evidence map›Paper›PMID 38469406›Full record

ArticleFrontiers in pharmacology2024

New insights into the anticancer effects of

Badriyah S Alotaibi, Thanaa A El-Masry, Hend Selim, Maisra M El-Bouseary, Mostafa M El-Sheekh, Mofida E M Makhlof, Maysa M F El-Nagar

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Badriyah S AlotaibiDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Thanaa A El-MasryDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Hend SelimDepartment of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Maisra M El-BousearyDepartment of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Mostafa M El-SheekhBotany Department, Faculty of Science, Tanta University, Tanta, Egypt.
Mofida E M MakhlofBotany and Microbiology Department, Faculty of Science, Damanhour University, Damanhour, Egypt.
Maysa M F El-NagarDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Tanta University · EGDamanhour University · EGPrincess Nourah bint Abdulrahman University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancerbrown algaemacroalgaeselenium nanoparticlessolid Ehrlich carcinoma

Identifiers

PMID38469406
PMCPMC10926956
OpenAlexW4391878445

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.